Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,731.60
(
1.56%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.70
(
0.00%
)
Bitcoin
79,875.90
(
0.75%
)
News Focus
News Focus
Post# of 44698
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Bu33ard

Send PM Follow Ignore
Followers 5
Posts 56
Boards Moderated 0
Alias Born 06/28/2020

Bu33ard

Re: randychub post# 12385

Saturday, 08/22/2020 11:17:51 AM

Saturday, August 22, 2020 11:17:51 AM

Post# of 44698
From the Article in Bio-World

"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials"

Very good news.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RLFTF News
More RLFTF News